From CRO client to CRO employee: An interview with Dr. Chris Teleha
While working in big pharma, Dr. Chris Teleha spent years working with CROs in the development […]
On the road again: Experiencing BioTrinity 2021 as our first 2021 live event
COVID-19 has changed how we interact with people and has forced us to re-evaluate how we […]
The ‘Art of API’
The timely availability of high-quality APIs accelerates further investigation by our clients. To meet these pressing API needs, Symeres enables a route-scouting investigation for the API of interest.
Renewal of the GMP certificate for Symeres Prague
This spring, Symeres Prague was audited by the national control authority SÚKL. After this audit, our […]
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer
Earlier this year, our client TOLREMO therapeutics nominated the clinical candidate for a chemical series that […]
Metabolites in Safety Testing (MIST) evaluation
A key goal of clinical trials is to evaluate whether the potential new drug reaches its […]
Symeres, a leading European CRO and CDMO, joins forces with Keensight Capital
Paris (France) – May 25th 2021 We are pleased to let you know that Keensight Capital, […]
The challenging and dynamic world of analytical chemistry
In this article, one of the senior scientists from our Analytical Department talks about the challenges she encounters.
Ton Vries: The man behind the award
Ton is a person of simple habits, long-lasting friendships, and a photographic memory for molecular structures. He believes in the power of chemistry.
